2nd June 2020

After careful consideration and extended discussions, BSAC Council has taken the decision to close our flagship Antimicrobial Resistance Surveillance Programme, and are inviting expressions of interest from academic or not-for-profit organisations who may be interested in adopting all/part of the isolate collection, which contains almost 100,000 isolates from a range of clinically significant species.

Initiated in 1999, the programme has provided much benefit to the research community and industry sponsors alike. A source of surveillance data from two clinical settings: bacteraemia and respiratory infections (community- and hospital-onset), throughout the UK and Ireland, the programme provided pharma with a means of susceptibility testing newly developed antimicrobial agents independently against a panel of generic agents using a standardised agar dilution MIC method.

While the surveillance programme is no longer viable in its current format, we recognise the value of this unique, longitudinal surveillance and are keen that the isolates and associated data (such as patient age, sex, regional location, specimen date, and MICs) are made available for further research to support the needs of the today’s AMR challenges.  For more information, or to register your interest in the collection, please contact: Tracey Guise (tguise@bsac.org.uk), BSAC CEO.

GP? Pharmacist? Researcher? Social Scientist? Whatever field you work in, if you’re committed to fighting infection then we want you to join us as a BSAC Member.
Become a member
I have read and agree to the Privacy Policy

Having trouble finding what you're after?

Top